153 related articles for article (PubMed ID: 33516936)
1. Lesion distribution and substrate of white matter damage in myotonic dystrophy type 1: Comparison with multiple sclerosis.
Leddy S; Serra L; Esposito D; Vizzotto C; Giulietti G; Silvestri G; Petrucci A; Meola G; Lopiano L; Cercignani M; Bozzali M
Neuroimage Clin; 2021; 29():102562. PubMed ID: 33516936
[TBL] [Abstract][Full Text] [Related]
2. Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1.
Labayru G; Diez I; Sepulcre J; Fernández E; Zulaica M; Cortés JM; López de Munain A; Sistiaga A
Neuroimage Clin; 2019; 24():102078. PubMed ID: 31795042
[TBL] [Abstract][Full Text] [Related]
3. Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS.
Elkady AM; Wu Z; Leppert IR; Arnold DL; Narayanan S; Rudko DA
Mult Scler Relat Disord; 2021 Nov; 56():103309. PubMed ID: 34688179
[TBL] [Abstract][Full Text] [Related]
4. Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
Reitz SC; Hof SM; Fleischer V; Brodski A; Gröger A; Gracien RM; Droby A; Steinmetz H; Ziemann U; Zipp F; Deichmann R; Klein JC
Brain Imaging Behav; 2017 Jun; 11(3):744-753. PubMed ID: 27138529
[TBL] [Abstract][Full Text] [Related]
5. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
[TBL] [Abstract][Full Text] [Related]
6. Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities.
Giorgio A; Dotti MT; Battaglini M; Marino S; Mortilla M; Stromillo ML; Bramanti P; Orrico A; Federico A; De Stefano N
J Neurol; 2006 Nov; 253(11):1471-7. PubMed ID: 16786209
[TBL] [Abstract][Full Text] [Related]
7. Myelin content changes in Clinically Isolated Syndrome and Relapsing- Remitting Multiple Sclerosis: Associations with lesion type and severity of visuomotor impairment.
Panou Τ; Kavroulakis E; Mastorodemos V; Pouli S; Kalaitzakis G; Spyridaki E; Maris TG; Simos P; Papadaki E
Mult Scler Relat Disord; 2021 Sep; 54():103108. PubMed ID: 34198031
[TBL] [Abstract][Full Text] [Related]
8. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
[TBL] [Abstract][Full Text] [Related]
9. DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS.
Preziosa P; Pagani E; Morelli ME; Copetti M; Martinelli V; Pirro F; Falini A; Comi G; Filippi M; Rocca MA
Mult Scler; 2017 Dec; 23(14):1918-1928. PubMed ID: 28098510
[TBL] [Abstract][Full Text] [Related]
10. Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.
Schneider-Gold C; Bellenberg B; Prehn C; Krogias C; Schneider R; Klein J; Gold R; Lukas C
PLoS One; 2015; 10(6):e0130352. PubMed ID: 26114298
[TBL] [Abstract][Full Text] [Related]
11. Automated separation of diffusely abnormal white matter from focal white matter lesions on MRI in multiple sclerosis.
Maranzano J; Dadar M; Zhernovaia M; Arnold DL; Collins DL; Narayanan S
Neuroimage; 2020 Jun; 213():116690. PubMed ID: 32119987
[TBL] [Abstract][Full Text] [Related]
12. Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis.
Liu Z; Pardini M; Yaldizli Ö; Sethi V; Muhlert N; Wheeler-Kingshott CA; Samson RS; Miller DH; Chard DT
Brain; 2015 May; 138(Pt 5):1239-46. PubMed ID: 25823475
[TBL] [Abstract][Full Text] [Related]
13. Cognitive Decline and White Matter Integrity Degradation in Myotonic Dystrophy Type I.
Lopez-Titla MM; Chirino A; Cruz Solis SV; Hernandez-Castillo CR; Diaz R; Márquez-Quiroz LDC; Magaña JJ; Beltrán-Parrazal L; Fernandez-Ruiz J
J Neuroimaging; 2021 Jan; 31(1):192-198. PubMed ID: 32936994
[TBL] [Abstract][Full Text] [Related]
14. Differences in splicing defects between the grey and white matter in myotonic dystrophy type 1 patients.
Nishi M; Kimura T; Igeta M; Furuta M; Suenaga K; Matsumura T; Fujimura H; Jinnai K; Yoshikawa H
PLoS One; 2020; 15(5):e0224912. PubMed ID: 32407311
[TBL] [Abstract][Full Text] [Related]
15. External Ophthalmoplegia and Brainstem White Matter Lesions: Presentation of Myotonic Dystrophy Type 1.
Igreja L; Ribeiro L; Cardoso M; Vasconcelos C; Santos E
Neurologist; 2023 Jan; 28(1):54-56. PubMed ID: 35442941
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal study in patients with myotonic dystrophy type 1: correlation of brain MRI abnormalities with cognitive performances.
Cabada T; Díaz J; Iridoy M; López P; Jericó I; Lecumberri P; Remirez B; Seijas R; Gomez M
Neuroradiology; 2021 Jul; 63(7):1019-1029. PubMed ID: 33237431
[TBL] [Abstract][Full Text] [Related]
17. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
[TBL] [Abstract][Full Text] [Related]
18. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
Herranz E; Giannì C; Louapre C; Treaba CA; Govindarajan ST; Ouellette R; Loggia ML; Sloane JA; Madigan N; Izquierdo-Garcia D; Ward N; Mangeat G; Granberg T; Klawiter EC; Catana C; Hooker JM; Taylor N; Ionete C; Kinkel RP; Mainero C
Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
[TBL] [Abstract][Full Text] [Related]
19. Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.
Ingrisch M; Sourbron S; Herberich S; Schneider MJ; Kümpfel T; Hohlfeld R; Reiser MF; Ertl-Wagner B
Invest Radiol; 2017 Mar; 52(3):135-141. PubMed ID: 27548346
[TBL] [Abstract][Full Text] [Related]
20. Perilesional neurodegenerative injury in multiple sclerosis: Relation to focal lesions and impact on disability.
Clarke MA; Lakhani DA; Wen S; Gao S; Smith SA; Dortch R; Xu J; Bagnato F
Mult Scler Relat Disord; 2021 Apr; 49():102738. PubMed ID: 33609957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
